Company |
Drug |
Indication |
Boehringer Ingelheim GmbH |
Jentadueto |
Type II diabetes |
Depomed Inc. |
Janumet XR |
Type II diabetes |
BioSante Pharmaceuticals Inc. |
Bio-T-Gel |
Male hypogonadism |
Corcept Therapeutics Inc. |
Korlym |
Hyperglycemia in Cushing's syndrome |
Novartis AG |
Gleevec |
CD117-positive gastrointestinal stromal tumor |
Vertex Pharmaceuticals Inc. |
Kalydeco |
Cystic fibrosis |